Suchergebnisse - "Fajgenbaum, David C"

PubPharm (6)

1

Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO

enthalten in: Journal of cellular and molecular medicine | 2022

von Phillips, A. | Kakkis, J. | Tsao, P. | +2

2

Transcriptome and unique cytokine microenvironment of Castleman disease

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022

von Wing, A. | Xu, J. | Meng, W. | +12

3

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2021

von Pierson, S. | Shenoy, S. | Oromendia, A. | +22

4

Increased mTOR activation in idiopathic multicentric Castleman disease

enthalten in: Blood | 2020

von Arenas, D. | Floess, K. | Kobrin, D. | +14

CommentIn: Blood. 2020 May 7;135(19):1614-1615. - PMID 32379877

5

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

6

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

1
[1]